Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Millennium Pharmacon International TbkISX:SDPC 79 Cyclically Adjusted PB Ratio is 0.79 as of Aug. 01, 2026, which is 18% above its 10-year median of 0.67. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 92 Medical Distribution companies, PT Millennium Pharmacon International Tbk ranks better than 73.91% on this metric.
ISX:SDPC's Cyclically Adjusted PB Ratio is ranked better than 73.91% of 92
companies
in the Medical Distribution industry
Industry Median: 1.14
vs ISX:SDPC: 0.79
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
PT Millennium Pharmacon International Tbk's adjusted book value per share data for the three months ended in Mar. 2026 was Rp255.517. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is Rp229.55 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
PT Millennium Pharmacon International Tbk (ISX:SDPC) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
PT Millennium Pharmacon International Tbk Cyclically Adjusted PB Ratio Related Terms
PT Millennium Pharmacon International Tbk Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Millennium Pharmacon International Tbk Cyclically Adjusted PB Ratio Chart
PT Millennium Pharmacon International Tbk Annual Data
ISX:SDPC vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison
For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Millennium Pharmacon International Tbk Cyclically Adjusted PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio falls into.
PT Millennium Pharmacon International Tbk Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 0.79 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Cyclically Adjusted PB Ratio of 0.79 as of Aug. 01, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Millennium Pharmacon International Tbk and its competitors. This is 18% above median its historical median of 0.67. Over the past decade, PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio has ranged from 0.53 to 1.69. According to the industry distribution chart, PT Millennium Pharmacon International Tbk ranks #24 out of 92 companies in the Medical Distribution industry, placing it in the top 26.1%.
Is PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio too high?
PT Millennium Pharmacon International Tbk's current Cyclically Adjusted PB Ratio of 0.79 is 18% above median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 1.69. The Medical Distribution industry median Cyclically Adjusted PB Ratio is 1.14. PT Millennium Pharmacon International Tbk's value of 0.79 is 30.7% below this industry median. Based on the distribution chart, PT Millennium Pharmacon International Tbk ranks #24 out of 92 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Cyclically Adjusted PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Millennium Pharmacon International Tbk ranks #24 out of 92 companies for Cyclically Adjusted PB Ratio. This puts PT Millennium Pharmacon International Tbk in the upper half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.14. PT Millennium Pharmacon International Tbk's value of 0.79 is 30.7% below this benchmark. Historically, PT Millennium Pharmacon International Tbk's own Cyclically Adjusted PB Ratio has ranged from 0.53 to 1.69 over the past decade. While the company's 10-year median is 0.67 vs. the industry median of 1.14, PT Millennium Pharmacon International Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Distribution company?
The median Cyclically Adjusted PB Ratio among Medical Distribution companies is 1.14, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Millennium Pharmacon International Tbk's current Cyclically Adjusted PB Ratio of 0.79 is 30.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Millennium Pharmacon International Tbk and its competitors. For the Medical Distribution industry, the median Cyclically Adjusted PB Ratio is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Millennium Pharmacon International Tbk's current Cyclically Adjusted PB Ratio is 0.79, which is 18% above median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 0.79, which is 18% above median its 10-year median of 0.67 and 30.7% below the Medical Distribution industry median of 1.14. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Cyclically Adjusted PB Ratio is 0.79 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued.
The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83.
GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.
Key valuation signals for ISX:SDPC:
Cyclically Adjusted PB Ratio: 0.79 (18% above median its 10-year median of 0.67)
GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
Industry Position: 30.7% below the Medical Distribution median (#24 of 92)
No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressJl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score
Get the complete analysis for ISX:SDPC
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SDPC has been successfully added to your 
